ClinicalTrials.govpublic full text
Study of Long-term Safety, Efficacy Tolerability of BYM338 in Patients With Sporadic Inclusion Body Myositis
sporadic inclusion body myositis (sibm), inclusion body myositis (ibm), interventional, phase2, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 845102
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.